We are live on
!
Find out more
PIM
Partner Investment Management Portfolio holdings
AUM
$13.9M
1-Year Est. Return
55.92%
This Fund
S&P 500
This Quarter
Est. Return
+12.7%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$66.4M
AUM Growth
-$179M
(-73%)
Cap. Flow
-$190M
Cap. Flow
% of AUM
-286.78%
Top 10 Holdings %
Top 10 Hldgs %
30.27%
Holding
112
New
25
Increased
15
Reduced
41
Closed
30
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jazz Pharmaceuticals
JAZZ
|
+$1.69M |
| 2 |
AerCap
AER
|
+$1.35M |
| 3 |
Pfizer
PFE
|
+$1.33M |
| 4 |
Illumina
ILMN
|
+$960K |
| 5 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$934K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vulcan Materials
VMC
|
+$21.4M |
| 2 |
Microsoft
MSFT
|
+$18.6M |
| 3 |
Bausch Health
BHC
|
+$10.7M |
| 4 |
MIC
Macquarie Infrastructure Holdings, LLC
MIC
|
+$7.46M |
| 5 |
AGN
Allergan Inc
AGN
|
+$7.37M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 51.77% |
| 2 | Industrials | 8.93% |
| 3 | Materials | 5.71% |
| 4 | Technology | 4.55% |
| 5 | Financials | 3.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ANAC
51
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $499K | 0.75% |
8,627
-1,425
| -14% | -$60.5K |
|
52
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.6B
| $482K | 0.73% |
+5,319
| New | +$481K |
|
|
SCHW
53
Charles Schwab
SCHW
$187B
| $475K | 0.72% |
+15,594
| New | +$452K |
|
54
Masco
MAS
$15.3B
| $474K | 0.71% |
20,223
-34,327
| -63% | -$779K |
|
|
OCR
55
DELISTED
OMNICARE INC
OCR
| $465K | 0.7% |
6,032
+207
| +4% | +$15.7K |
|
56
Williams-Sonoma
WSM
$29.6B
| $464K | 0.7% |
+11,650
| New | +$462K |
|
|
BLUE
57
DELISTED
bluebird bio
BLUE
| $447K | 0.67% |
286
-514
| -64% | -$678K |
|
|
ALDR
58
DELISTED
Alder Biopharmaceuticals
ALDR
| $444K | 0.67% |
15,391
+7,969
| +107% | +$219K |
|
|
ACOR
59
DELISTED
Acorda Therapeutics
ACOR
| $386K | 0.58% |
97
-163
| -63% | -$747K |
|
60
Aramark
ARMK
$14.7B
| $371K | 0.56% |
+16,225
| New | +$372K |
|
61
Delta Air Lines
DAL
$60.1B
| $350K | 0.53% |
+7,792
| New | +$361K |
|
62
QuidelOrtho
QDEL
$838M
| $321K | 0.48% |
11,897
+6,621
| +125% | +$169K |
|
|
WCG
63
DELISTED
Wellcare Health Plans, Inc.
WCG
| $319K | 0.48% |
3,486
-17,767
| -84% | -$1.48M |
|
|
ATHN
64
DELISTED
Athenahealth, Inc.
ATHN
| $318K | 0.48% |
+2,660
| New | +$355K |
|
65
Agilent Technologies
A
$41.2B
| $302K | 0.45% |
7,274
-90,027
| -93% | -$3.64M |
|
66
Bruker
BRKR
$8.14B
| $290K | 0.44% |
15,675
-3,166
| -17% | -$60K |
|
67
Halliburton
HAL
$26.6B
| $241K | 0.36% |
+5,484
| New | +$229K |
|
68
Carnival Corporation Ltd
CCL
$39.7B
| $239K | 0.36% |
+4,996
| New | +$225K |
|
69
Netflix
NFLX
$309B
| $228K | 0.34% |
+38,360
| New | +$233K |
|
|
ARAV
70
DELISTED
Aravive, Inc. Common Stock
ARAV
| $218K | 0.33% |
1,981
-1,296
| -40% | -$152K |
|
71
Acadia Pharmaceuticals
ACAD
$5.03B
| $198K | 0.3% |
6,084
-514
| -8% | -$17.7K |
|
|
KITE
72
DELISTED
Kite Pharma, Inc.
KITE
| $189K | 0.28% |
3,283
-474
| -13% | -$31.8K |
|
73
Integra LifeSciences
IART
$1.34B
| $186K | 0.28% |
+7,371
| New | +$174K |
|
|
AERI
74
DELISTED
Aerie Pharmaceuticals
AERI
| $181K | 0.27% |
+5,767
| New | +$167K |
|
|
HDP
75
DELISTED
Hortonworks, Inc.
HDP
| $137K | 0.21% |
5,731
+3,410
| +147% | +$79.2K |
|
Similar funds
SWM
ACM
ECAU
SL
DII
FIM
EM
BHC
Partner Investment Management's Q1 2015 Portfolio in Review
As of Q1 2015, Partner Investment Management held 112 positions worth $66.4M, down 73% from $245M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Partner Investment Management withdrew a net $190M in Q1 2015, closing 30 positions and reducing 41 holdings. Its most notable exit was Microsoft, an estimated $18.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 52% of assets, up from 44% a quarter earlier, followed by Industrials and Materials.
Against the trend, Partner Investment Management opened a new position in Jazz Pharmaceuticals worth $1.7M.
- Partner Investment Management's largest Q1 2015 buy was Jazz Pharmaceuticals: 9,850 shares worth $1.7M.
- Partner Investment Management added most to Illumina in Q1 2015, an estimated $960K increase.
- Partner Investment Management's biggest Q1 2015 reduction was Vulcan Materials, cutting an estimated $21.4M.
- Partner Investment Management fully exited Microsoft in Q1 2015, selling an estimated $18.6M.
- Partner Investment Management's ten largest holdings make up 30% of its $66.4M portfolio in Q1 2015.
- Partner Investment Management opened 25 new positions and closed 30 in Q1 2015.
- Partner Investment Management's portfolio value fell 73% quarter-over-quarter to $66.4M.
Based on Partner Investment Management's 13F filing for Q1 2015, filed 15 May 2015.